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Synopsis 
Neurotrophins are growth factors that are important in neuronal development and survival 
as well as synapse formation and plasticity.  Many of the effects of neurotrophins are 
mediated by changes in protein expression as a result of altered transcription or 
translation.  To determine if neurotrophins regulate the production of microRNAs, small 
RNA species that modulate protein translation, we used deep sequencing to identify 
BDNF induced microRNAs in cultured primary cortical mouse neurons. This revealed 
that the miR-212/132 cluster contained the microRNAs most responsive to BDNF 
treatment. This cluster was found to produce four microRNAs; miR-132, miR-132*, 
miR-212, miR-212*. Using specific inhibitors, mouse models and promoter analysis we 
have shown that the regulation of the transcription of the miR-212/132 microRNA cluster 
and the microRNAs derived from it are regulated by the ERK1/2 pathway, via both MSK 




miRNA, MSK1, MSK2, BDNF, neuron, MAPK 
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Introduction 
Neurotrophins comprise a family of growth factors that are important for both 
neuronal development and survival as well as synapse formation and plasticity.  Four 
neurotrophins have been identified in mammalian cells, NGF, BDNF, NT3 and NT4 
(reviewed in [1-5]).  NGF functions by activating the TrkA receptor, while BDNF and 
NT4 act via TrkB.  NT3 binds most strongly to TrkC, however under some circumstances 
it may also be able to act via TrkA and TrkB.  In addition all four neurotrophins may be 
able to stimulate cells via p75NTR, a member of the TNF receptor superfamily. 
Binding of neurotrophins to Trk receptors results in the activation of the tyrosine 
kinase domain in the receptor.  This leads to activation of several intracellular signalling 
pathways, including the ERK1/2, PI 3-kinase and PLC pathways [1-5].  These signalling 
cascades promote the effects of neurotrophins via multiple mechanisms, however an 
important aspect of their function is to regulate specific changes in gene transcription.  
These transcriptional changes are critical for many of the effects of neurotrophins.  While 
neurotrophic stimulation can affect the expression of hundreds of genes, less is 
understood about the roles of many of the individual genes in mediating the downstream 
effect of neurotrophins.  To date, most studies have focused on the  neurotrophin induced 
expression of protein encoding genes, however recently the gene encoding the microRNA 
miR-132 has been shown to be transcriptionally induced by neurotrophins [6]. 
microRNAs are small (21-24nt) regulatory RNAs that regulate gene expression 
post-transcriptionally by altering the translation of their target mRNAs.  In the genome, 
microRNAs can be located in either the introns of protein coding and non-coding genes, 
exons of non-coding genes or in intragenic regions [7].  The first step in microRNA 
production is the transcription and processing of a primary microRNA (pri-miRNA).   
The majority of pri-miRNAs are first processed by the Microprocessor complex in the 
nucleus releasing a hairpin structured pre-miRNA [8-10].  The pre-miRNAs are then 
exported into the cytoplasm where they are further processed by Dicer into a small 
double stranded intermediate [10-12]. One strand of a microRNA is loaded into RISC 
(RNA Induced Silencing Complex) of which a key component is an Argonaute protein 
[13-16].  Activated microRNA complexes can either cleave their target mRNA or 
regulate its translation, through a variety of mechanisms [17]. In vivo, microRNAs have 
been shown to modulate several processes including development, immunity and 
neuronal function.  In addition microRNAs may have pathological roles, for instance in 
cancer and tumorogenesis [18]. 
It is possible that neurotrophins may induce other microRNAs in addition to miR-
132 and that this could represent a mechanism of fine-tuning the protein expression 
following neurotrophic stimulation.  We therefore looked to see what effect BDNF 
stimulation had on the overall expression of microRNAs in cultured cortical neurons. We 
have found that only the miR-212/132 cluster reproducibly produces microRNAs upon 
BDNF induction.  Analysis of the signalling cascades required for the induction of the 
miR-212/132 cluster revealed a critical role for the ERK1/2 pathway. 
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Materials and methods 
 
Oligonucleotides 
The following RNA oligonucleotides (Dharmacon) were used in this study: mmu-
miR-132 - UAACAGUCUACAGCCAUGGUCG, mmu-miR-132 complementary 
sequence (used as a probe for Northern hybridization) - 
CGACCAUGGCUGUAGACUGUUA: mmu-miR-212 - 
UAACAGUCUCCAGUCACGGCC, mmu-miR-212 complementary sequence (used as a 
probe for Northern hybridization) - GGCCGUGACUGGAGACUGUUA. 
 
Mice and cell culture 
MSK1 and MSK2 knockout and Nestin-CRE transgenic mice have been described 
previously [19-21].  Macrophage specific knockin of CREB has been described 
previously [22], and CREB Ser133Ala mice described here were crossed onto a Nestin-
CRE background to achieve neuronal mutation of CREB.  All mice lines used had been 
backcrossed onto C57Bl/6 for at least 6 generations. 
Cortical cultures were isolated as described [23] and cultured in Neurobasal A 
supplemented with 2 % B27, 1 mM L-glutamine, 100 U/ml penicillin, and 0.1 mg/ml 
streptomycin and plated on poly-D-lysine-coated plates (100 µg/ml).  HeLa cells were 
maintained in DMEM suplemented with 10 % FBS, 5 mM L-glutamine, 100 U/ml 
penicillin, and 0.1 mg/ml streptomycin.  HeLa cells were serum starved for 16 h before 
stimulation. 
Where indicated cells were incubated with PD 184352 (2 µM), SB 203580 (5 
µM), Kn93 30 µM), PI-103 (10 µM) Bi-D1870 (5 µM) or MK 801 (10 µM) for 1 h 
before stimulation.  Cells were stimulated with BNDF (50 ng/ml), PMA (400 ng/ml) 
anisomycin (10 mg/ml).  For RNA isolation, cells were lysed and RNA isolated using 
microRNeasy mini kits (Qiagen) in line with the manufacturer’s protocol.  For 
immunoblotting neurons were lysed directly into SDS sample buffer while HeLa cells 
were lysed into 50 mM Tris/HCl, pH 7.5, 1 mM EGTA, 1 mM EDTA, 1 mM sodium 
orthovanadate, 50 mM sodium fluoride, 1 mM sodium pyrophosphate, 0.27 M sucrose, 
1% (v/v) Triton X-100, 0.1% (v/v) 2-mercaptoethanol and centrifuged at 13000g for 5 
min at 4oC to remove insoluble material. 
 
Sequencing and analysis 
 Purified total RNA from unstimulated primary cortical neurons or neurons 
stimulated with 50 ng/ml BDNF was separated on poly-acrylamide gels and the band 
corresponding to small RNAs was excised. cDNA libraries were generated containing 
small RNA sequences by ligation of adapters attached to both ends, and sequencing 
carried out using Solexa technology.  A total of 2,217,376 and 3,696,184 raw sequence 
reads were obtained for the unstimulated  and BDNF stimulated samples. The native 
RNA sequences were retrieved by removing the 3’ ‘TCGTATGCCGTCTTCTGCTTG’ 
adaptor tag. Removal of the adaptor tag was performed with a perl script allowing for 
inexact matching. Searching from the 5’ end of each read a minimum length match of 
four bases was required which was then extended to the end of the reads allowing for up 
to three correctly matched tag bases for every one mismatched. Any reads containing 
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(A)13 poly-A bases or unknown bases were removed. 
Quality filtering was then performed similar to that previously described [24], where 
starting from the 5’ end of each read, a minimum quality score of 20 was required over a 
sliding window of four bases. Sequence reads were clipped at the first position where the 
mean quality dropped below 20. The quality filtered reads where then collated to their 
unique examples, but only including those longer than 16 bases in length and with an 
abundance count of >1. This filtering resulted in 62,613 unique sequences totaling 
2,213,730 reads for the control dataset, and 127,734 unique sequences totaling 3,692,981 
reads for the BDNF stimulated dataset. 
Sequence matching the collated reads was performed with the Vmatch algorithm 
[25] against annotated non-coding RNAs (ncRNAs) (Ensembl release 52) [26] and 
annotated microRNA hairpin sequences (miRBase release 12) [27]. The full complement 
of tRNA sequences were added to the downloadable ncRNA dataset from Ensembl via a 
perl script accessing the Ensembl API. All Vmatch runs were performed allowing for up 
to two mismatches and only matches with the fewest mismatches were retained for each 
read. 
The read abundance for the two samples is significantly different making comparisons 
problematic. Therefore, the absolute read numbers were normalized relative to the total  
abundance of pre-miRNA sequences in each dataset thus making comparisons of changes 
between the samples more straightforward.  Simple counts of sequence reads have an 
estimated error of n1/2 [28] and the control and BDNF errors were propagated through to 





























where r, B and C are the values for BDNF/Control ratio, BDNF and Control data, 




For PCR of mRNA or intron sequences, total RNA was reverse transcribed with 
iScript (Biorad) in line with the manufacturer’s protocols.  Q-PCR was carried out using 
SYBERgreen detection.  The PCR program consisted of an initial activation step of 3 min 
at 95oC, followed by 40 cycles of 20 sec at 95oC and 45 sec at 58oC.  Fold induction was 
calculated relative to the unstimulated control (wild type) sample, using 18s levels to 
correct for loading [29].  Primer sequences used are given in supplementary table 2. 
Q-PCR for mature microRNA was carried out using TaqMan MicroRNA assays 
from Applied Biosystems according to the manufacturer’s protocols.  miR-16 levels were 
used to correct for total RNA levels. 
 
Mir-212/132 promoter luciferase reporter constructs 
4.553 kb of the mouse miR212/132 promoter was amplified from mouse BAC 
clone (RP23-142A14)) in two halves using oligonucleotides 5’-
gaggatccggaaggttctgtcttcaaatgaggaactc-3’ and 5’-catgcggccgcggctcctacac-3’ for the 5’ 
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portion and oligonucleotides 5’-gccgcggccgcatgaatgagc-3’ and 5’-
ctaagcttctcgccaccttaggcagcgatac-3’ for the 3’ portion using KOD Hot Start DNA 
polymerase (Novagen). The purified PCR products were cloned into BglII/HindIII of 
pGL4.11(luc2P) (Promega Corporation) in a three-way ligation using BamH1-Not1-
Hind111. The resulting full-length clone was fully sequenced. 
5’ truncations of the promoter were created by introducing an Xho1 site within the 
promoter sequence by PCR mutagenesis using KOD Hot Start DNA polymerase 
(Novagen).  The resulting Xho1 fragment was then removed by digestion and gel 
purification, followed by re-ligation of the vector.  A 3’ truncated promoter was made by 
re-amplifying the shorter promoter sequence from the full length clone and cloning as a 
BamH1/HindIII fragment into BglII/HindIII of pGL4.11(luc2P).  Mutations of the 
consensus CRE sites were also generated by PCR mutagenesis, and changed the GCAG 
core region of the CRE consensus to TAAA.   Primer sequences used for mutagenesis are 
given in supplementary table 3. 
 
Transfection 
Cortical cultures were transfected with promoter-firefly (0.25 µg/well) and control 
renilla (pRL-TK, Promega) luciferase plasmids (0.1 µg/well) using Lipofectamine 2000 
(Invitrogen) transfection reagent. Two days after the transfection the cells were 
stimulated with BDNF (50 ng/ml) for 3 hours, then the cells were lysed with 1X passive 
lysis buffer. The luminescence of the samples was measured by a luminometer 
(Microlumat plus LB96, Berthold Technologies). 
 
Immunoblotting 
Samples were run on 10 % polyacrylamide gels and transfered onto nitrocellulose 
membranes using standard protocols.  The antibodies against total ERK1/2 was from Cell 
Signalling and the phospho Ser133 CREB  monoclonal antobody was from Millipore.  
Detection was acheived using horseradish peroxidase conjugated secondary antibodies 
(Pierce) and chemiluminescent substrate (Amersham). 
 
Northern hybridizations 
10 µg of total RNA was separated on 15% polyacrylamide gels containing 7M Urea and  
20 mM MOPS/NaCl pH7.0.  The RNAs were transferred onto Hybond N (Amersham) 
nylon membrane by semi-dry blotting.  For the detection of the small RNAs we followed 
the published protocol for sensitive Northern blotting using chemical cross linking [30] 
with the only modification that the filters were washed for two times for an hour at 65oC 
with 0.1 % SDS, 2 X SSC. Detection and quantification of the signals were carried out as 
it was described above. 
 
3´ RACE analysis 
1 µg Qiazol (Qiagen) extracted total RNA was subjected to first strand synthesis 
with Superscript III (Invitrogen) reverse transcriptase at 50oC for 1 hour. First and nested 
PCR reactions were carried out with KOD hot start DNA polymerase (NOVAGEN). 
Amplified DNA sequences were cloned and transformed using the StratacloneTM Blunt 
PCR Cloning Kit  (Stratagene). 8-8 positive clones were sequenced and the sequences 
were analyzed with Vector NTI software (Invitrogen). 
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Results 
MicroRNA expression in cortical neurons 
Primary cortical neuronal cultures were established from C57Bl/6 mice. Total 
RNA was isolated from both unstimulated cells and cells that had been stimulated with 
BDNF for 24h, and microRNA expression analysed by Solexa sequencing.  The output 
from the sequencing was filtered and collated into unique examples and then searched 
against known pre-microRNAs as well as other known RNAs as detailed in Table 1. This 
showed that the vast majority of the isolated RNA matched to pre-miRNA sequences in 
both samples.  In the unstimulated sample, the matches corresponded to 330 individual 
pre-miRNA sequences from the 547 mouse pre-microRNAs annotated in miRBase [27].  
Of these, 202 were represented by 10 or more hits. For the BDNF stimulated sample, 
there were 373 individual pre-miRNA matches with 243 having an abundance of at least 
10 reads. In both samples, the vast majority of sequences (>90%) corresponded to let-7 
isoforms.  The detailed breakdown of the pre-miRNA matches can be found in 
Supplementary Table 1. 
Analysis of the normalised expression changes between the control and BDNF 
stimulated data showed that the expression of most of the microRNAs was similar 
between the two samples (Fig 1a, Supplementary Table 1).  12 pre-miRNAs had absolute 
fold changes of >4 and are shown in Table 2. However, most had fewer than 5 reads in 
the control sample meaning that the changes were unlikely to be statistically meaningful.   
Consistent with this, Q-PCR for miR-712 and miR-194-1 showed no upregulation of 
these microRNAs following BNDF treatment (data not shown). Filtering out pre-
miRNAs with fewer than 5 reads left 4 pre-miRNAs with a fold change of greater than 4: 
miR-98, miR-146a, miR-212 and miR-132  (Table 2). 
To confirm the sequencing data, the expression of miR-98, miR-146a, miR-212 
and miR-132, along with several other microRNAs that were not expected to change was 
examined by Q-PCR in a second set of samples, independent to those used for sequencing 
(Table 3 and Figure 1B). For each of the selected microRNAs, alignments of the 
sequencing hits to the hairpin sequence where examined to determine if the 5p or 3p 
sequences were expressed.  In most cases, the sequences found matched the main species 
annotated in miRBase, however not all of the annotated star sequences were observed 
(Table 3).  The exceptions to this were miR-132 and miR-212, where in addition to the 
annotated 3p sequence, the 5p sequence (* sequence) was also observed.  In addition for 
miR-132, a sequence corresponding to the hairpin loop region was also sequenced 
(Supplementary Figure 1).  Comparison between the Q-PCR data and sequencing data 
showed that while there was reasonable agreement between the two methods for the non–
induced microRNAs  (Fig 1A, table 3), only two of the 4 upregulated microRNAs from 
the sequencing data were reproduced in the Q-PCR analysis.  Using Q-PCR, miR-98 and 
miR-146a were not significantly upregulated (p-value > 0.01) after 4 or 24h of BDNF 
treatment (Table 1, data not shown).  The lack of miR-98 upregulation in the Q-PCR was 
unexpected, given the high abundance (up to 74,250 reads) in the sequencing experiment 
would suggest that this should be one of the more reproducible results.  miR-98 is part of 
the let-7 family and given the very high expression of other let-7 isoforms in the neurons 
it is possible that either the Q-PCR was not sufficiently specific for miR-98 relative to the 
other let-7 isoforms or that the read matching for the sequencing data, which allowed up 
to 2 mismatches, could not always differentiate between miR-98 and other let-7 isoforms.  
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To examine this, the sequencing data was reanalysed allowing for 0 mismatches.  Under 
this more stringent analysis, the number of miR-98 matches fell, while the fold change 
between the control and BDNF sample decreased to 1.22, a value similar to that obtained 
by Q-PCR.  Both miR-132 and miR-212 were still induced using this analysis method. 
Of the microRNAs tested only miR-132 and miR-212 were upregulated 
consistently by BDNF in both the sequencing and Q-PCR data (Fig 1B).  Upregulation of 
both miR-132 and miR-212 by BNDF could also be demonstrated by Northern blotting 
(Fig 1C).  Interestingly both miR-132 and miR-212 map to the same genomic locus 
suggesting that their expression may be co-regulated.  miR-132 has previously been 
shown to be upregulated in neuronal cells following neurotrophic stimulation [6], and has 
been suggested to be involved in the regulation of MeCP2 and p250Gap in neurons [31, 
32]. The regulation of miR-212 expression has not however previously been studied in 
neuronal cells.  The regulation of miR-132 and miR-212 transcription was therefore 
examined in more detail. 
 
 
BDNF promotes transcription of the miR-212/132 locus in murine cortical neurons 
 
In mice, both miR-132 and miR-212 localise to the same region of chromosome 
11.  Both microRNAs are also found in an equivalent localisation in other species 
including the human and rat genomes.  In rats, miR-132 has been shown to be processed 
from the intron of a small non-coding RNA gene [6].  Analysis of mouse ESTs revealed 
evidence for a similar non-coding gene in mice, consisting of 3 exons with miR-132 and 
miR-212 located in intron 1 (Fig 2A).   To examine the transcription of this gene, PCRs 
were designed to amplify regions from intron 1, exon 2, intron 2 and exon 3.  In addition 
primers were also made to amplify PCR products from exons 1 to 2 and from 2 to 3.  
Using Q-PCR, it was found that stimulation of primary cortical neurons with BDNF was 
able to induce the transcription of this non coding mRNA using primer sets that amplified 
either the exon1/2 or exon 2/3 fragments (Fig 2B).  Cloning of these PCR products 
confirmed that the splicing predicted from the ESTs had occurred (data not shown).  
The induction of exons 2 and 3 as well as introns 1 and 2 was also examined by 
Q-PCR using the primer sets internal to these regions (Fig 2).  In this case, the absolute 
amounts of the products were determined for each PCR using a standard curve prepared 
from a plasmid containing a subclone of the miR-212/132 genomic locus.  All four 
regions were induced by BDNF, however the absolute levels of intron 1 were lower than 
exon 2, consistent with the rapid processing of this intron by the microprocessor pathway 
[33].  Unexpectedly, the absolute levels of exon 3 were much lower than exon 2 (Fig 2C).  
Analysis of the intron 2 sequence revealed 3 potential poly-adenylation sites.  3’ RACE 
confirmed that termination could occur at least 2 of these sites in addition to the poly 
adenylation site 3’ to exon 3 (supplementary figure 2).  This would suggest that an 
alternative transcript, with a longer version of exon 2 but lacking exon 3 was also 
produced.  Consistent with this, Q-PCR using primers in the 5’ region of intron 2 gave 
similar results to primers for exon 2 (Fig 2C).  This would suggest that the predominant 
form expressed following BDNF stimulation corresponded to termination at the poly-





ERK1/2 regulates pri-miR-212/132 transcription. 
BDNF is known to stimulate a number of intracellular signalling cascades, leading to the 
activation of the ERK1/2, CaMK and PI 3-kinase pathways.  To determine which of these 
pathways were involved in miR-212/132 transcription small molecule inhibitors of these 
proteins were used.  Profiling of the specificity of these inhibitors has been reported 
previously [34].  PI-103, a specific PI-3 kinase inhibitor, SB 203580, a p38α/β MAPK 
inhibitor, and KN 93, a CaMK inhibitor, did not affect the transcription of pri-miR-
212/132 in response to BDNF  (Fig 3A).  In contrast PD 184352, a MEK1/2 inhibitor that 
blocks the activation of ERK1/2, completely blocked the induction of pri-miR-212/132 in 
response to BDNF (Fig 3A).   The upregulation of the mature microRNA was also 
determined using a Taqman based PCR system.  As star sequences were also identified in 
the sequencing data for both miR-132 and miR-212 the induction of these sequences was 
also examined by Q-PCR.  Both miR-132 and miR-212 were upregulated by BNDF 
stimulation, and consistent with the data on the pri-miR-212/132, PD184352 blocked the 
accumulation of the mature sequences in response to BNDF (Fig 3B).  In line with what 
was observed for miR-132 and miR-212, the * sequences of both microRNAs were also 
up regulated by BDNF in an ERK1/2 dependent manner (Fig 3B).  To determine absolute 
levels for each microRNA, Q-PCR was carried out and levels determined relative to a 
standard curve prepared using a synthetic oligo corresponding to each microRNA 
sequence.  This showed that miR-132 was expressed at much higher levels than miR-
132*.  Both the miR-212 and miR-212* sequences were found at similar levels, however 
these levels were significantly lower than that found for miR-132 (Fig 3C).  This was in 
contrast to the sequencing data which suggested that miR-212* might be expressed at a 
higher level than miR-212.  This difference could possibly be due to a ligation basis in 
the sequencing library that could result in an over representation of miR-212* in the 
library. 
 
MSK1/2 regulate pri-miR-212/132 transcription via the phosphorylation of CREB. 
ERK1/2 is able to regulate transcription both by the direct phosphorylation of 
specific transcription factors and by the activation of downstream kinases, such as RSK 
and MSK, that can in turn phosphorylate both transcription factors and chromatin [22, 
35].  Bi-D1870, a specific RSK inhibitor [36], did not affect the induction in pri-miR-
212/132 transcription in response to BDNF, indicating that ERK1/2 controlled pri-miR-
212/132 induction independently of RSK (Fig 3A).  Analysis of cortical cultures from 
MSK1/2 double knockout mice showed that while BDNF was able to induce pri-miR-
212/132 transcription in these cells, the levels were consistently lower than those seen in 
wild type cells (Fig 4A), suggesting that MSKs were partially, but not completely, 
responsible for regulating pri-miR-212/132 transcription downstream of ERK1/2.  
Consistent with this MSK1/2 knockout also reduced the induction of the mature and star 
sequences for both miR-132 and miR-212 (Fig 4B).  MSKs have previously been shown 
to phosphorylate CREB on Ser133 downstream of ERK1/2 [19, 23], and CREB has 
previously been suggested to regulate miR-132 transcription [6].  Previous studies in 
primary cortical neuronal cultures have shown that CREB phosphorylation in response to 
BDNF is blocked by the MEK1/2 inhibitor PD 184352 and is greatly reduced by MSK1/2 
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knockout [23].  Analysis of the genomic sequence around miR-132 and miR-212 revealed 
a 500 bp region upstream of exon1 that was conserved in mouse and human, suggesting 
that this may contain the critical promoter elements.  This 500bp region contains a 
potential CRE site, and in addition three further potential CRE consensus sites could be 
identified in intron 1.  To analyse this further, the region from 3105bp upstream of exon 1 
to the start of exon 2 was cloned into a luciferase reporter (Fig 5A).  This reporter was 
induced by BDNF in primary cortical neurons, and similar to the endogenous gene its 
induction was blocked by PD 184352 (Fig 5B).  In addition two truncations of this 
promoter were also generated (Fig 5A).  These showed that while the long form of the 
promoter has the highest activity, a short form starting 475 bp 5’ to exon 1 also showed 
significant induction by BDNF (Fig 5C).  This sequence contains all four of the potential 
CRE sites (Fig 5A).  Deletion of the intron 1 region (which contains three of the four 
CRE sites) was sufficient to greatly reduce expression of the luciferase vector (Fig 4C).  
Mutation of the three intronic CRE sequences however was not enough to abolish 
promoter activity.  In contrast, mutation of the 5’ CRE site did reduce the induction of the 
reporter, while mutation of all four CRE sites resulted in an even greater reduction in the 
induction of the reporter by BDNF (Fig 5D).  The requirement for these CRE sites is 
consistent with a previous report showing that A-CREB, a dominant negative inhibitor of 
CREB, could block miR-132 induction and that CREB could bind to this region as 
judged by ChIP [6].  Classically CREB is regulated by phosphorylation on Ser133, which 
creates a binding site for the co-activator proteins CBP or p300 [37, 38].  We therefore 
also examined the role of CREB in miR-212/132 transcription using mice with an 
inducible Ser133Ala mutation in the endogenous CREB gene [39].  In this system, a 
Ser133Ala mutation in the CREB gene is induced by the excision of a wild type floxed 
minigene from the endogenous CREB gene by CRE recombinase.  To specifically induce 
this mutation in neuronal cells, CRE expression was driven from a nestin promoter 
sequence, that has previously been shown to express CRE in neuronal progenitor cells 
during development [21].  Previous studies have confirmed that primary cortical neuronal 
cultures from these mice express the mutated Ser133Ala CREB but not the wild type 
protein [39].  BDNF induced pri-miR-212/132 transcription was reduced in Ser133Ala 
CREB knock-in neuronal cultures compared to wild type cells (Fig 6A).  The reduction in 
pri-miR-212/132 transcription in CREB Ser133Ala knockin cells is in line with that seen 
in the MSK1/2 double knockout cells, the kinases responsible for BDNF induced CREB 
phosphorylation (compare Fig 6A and Fig 4A).  It is however in contrast to the effect of 
the MEK inhibitor PD 184352 on miR-212/132 transcription as the inhibitor completely 
blocked the induction of this gene by BDNF.  This suggests that ERK1/2 may also 
regulate miR-212/132 transcription via a second mechanism independent of MSK1/2 and 
CREB phosphorylation.  To confirm this, MSK1/2 knockout cells were treated with PD 
184352.  The residual induction of pri-miR-212/132 seen in these cells was blocked by 
PD184352 (Fig 6B).  
 
Regulation of pri-miR-212/132 transcription is not restricted to neurotrophic 
signalling. 
Several other stimuli are known to induce CREB phosphorylation in neurons.  
Forskolin elevates cAMP levels, resulting in PKA activation and CREB phosphorylation 
in a number of cell types including cortical neurons independently of ERK1/2 and 
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MSK1/2 [22].  Forskolin stimulation resulted in a sustained increase in pri-miR-212/132 
in cortical neurons (Fig 7A).  Consistent with this, forskolin was also able to stimulate the 
induction of the miR-212/132 promoter construct.  Mutation of the four Cre sites in this 
construct blocked induction (Fig 7B).  NMDA, a mimic of the neurotransmitter 
glutamate, was also able to stimulate pri-miR-212/132 transcription (Fig 7C).  Similar to 
BDNF and forskolin, NMDA could also stimulate the wild type but not CRE mutant 
miR-212/132 promoter construct (Fig 7D).  NMDA stimulates CREB phosphorylation 
via both the CaMK and ERK1/2 pathways.  Inhibition of either of these pathways 
reduced NMDA induced CREB phosphorylation, while inhibition of both pathways had 
an additive effect (Fig 7E).  Consistent with this, inhibition of either the ERK1/2 or 
CaMK signalling cascades partially blocked pri-miR-212/132 induction by NMDA, while 
a combination of both inhibitors had an additive effect (Fig 7F).  Both CREB 
phosphorylation and pri-miR-212/132 induction by NDMA were blocked by MK-801, an 
NDMA receptor antagonist (Fig 7E and F).  Induction of miR-132 and miR-212 was not 
restricted to neuronal lineages.  Treatment of HeLa cells with either PMA or anisomycin 
was able to induce pri-miR-212/132 transcription via the ERK1/2 or p38a MAPK 
pathway respectively, while pri-miR-212/132 transcription was also induced by LPS 
(which activates both ERK1/2 and p38) in THP-1, a human monocyte cells line, although 




The transcriptional up-regulation of specific microRNA genes is a potential 
mechanism by which signal transduction cascades could mediate their cellular functions.  
Some examples of this have already been reported; for instance the induction of the miR-
17/92 cluster by IL-6 is reported to be responsible for the effect of IL-6 on BMPR2 
expression [40] while the upregulation of miR-146a by TLRs is suggested to play a role 
in negative feedback loops involved in controlling TLR signalling [41].  BDNF has 
previously been shown to upregulate miR-132 expression, however the effect of BDNF 
on the expression of other microRNAs has not previously been addressed (38).  Using 
Solexa sequencing, BDNF was found to upregulate four microRNAs with significant 
abundances, of which two, miR-132 and miR-212, could be confirmed by Taqman based 
Q-PCR.  Both miR-132 and miR-212 are encoded by a single noncoding gene.  The 
transcription of pri-miR-212/132 in response to BDNF was dependent on the activation 
of ERK1/2.  In addition, it was found that the phosphorylation of CREB by MSKs 
downstream of ERK1/2 was also involved in pri-miR-212/132 transcription.  Consistent 
with a role for CREB, ChIP experiments have previously shown the binding of CREB to 
the miR-212/132 locus (45).  In addition ERK1/2 also regulated pri-miR-212/132 via a 
MSK/CREB Ser133 phosphorylation independent mechanism.  The identity of this 
mechanism is not clear.  It is possible that ERK1/2 could affect the activity of CREB in a 
manner independent of Ser133 phosphorylation, for instance by affecting the recruitment 
of the CREB co-activator TORC.  This would be consistent with the observation that A-
CREB, a dominant negative form of CREB that prevents CREB binding to DNA, inhibits 
pri-miR-212/132 transcription in response to BDNF (38).  It is also possible however that 
ERK1/2 may regulate pri-miR-212/132 transcription via the phosphorylation of a 
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different transcription factor that has not yet been found to be associated with the miR-
212/132 promoter. 
The processing and maturation of the miR-212/132 cluster also bear some 
remarkable characteristics.  The intron that encodes the microRNA cluster is processed 
independently and faster than the rest of the pri-miRNA. This finding supports the view 
that intronic microRNAs are processed by the Microprocessor co-transcriptionally a 
priori to splicing [33]. Additionally, it is very unusual that microRNAs with such a low 
basal expression like miR-212 and 132 (judging from the number of the reads obtained 
from the sequencing data and the intensity of Northern hybridizations) show the 
accumulation of the star sequences. Moreover, all strands derived from this microRNA 
cluster respond to BDNF treatment. This may suggest that there is an active mechanism 
that facilitates the processing of all strands from the miR-212/132 cluster generating four 
functional microRNAs. In addition, a 19 nt sequence corresponding to the loop sequence 
of pre-miR-132 was shown to be increased upon BDNF treatment. It is unlikely that this 
sequence is an additional “microRNA” product from pre-miR-132 but it may accumulate 
because it is protected by protein that binds to the loop when miR-132 is processed. 
microRNA processing could be post-transcriptionally regulated and proteins that 
modulate pri- and pre-miRNA processing have been identified [42-45]. HnRNP A1 was 
shown to be required for the processing of miR-18 by binding to the terminal loop of the 
microRNA [46, 47]. In addition, common RNA binding proteins have been shown to 
bind to the loops of distinct microRNAs and predicted to have similar functions to 
hnRNP A1 [46]. The common characteristic of these microRNAs is that their loop 
sequences are extremely conserved throughout the vertebrates suggesting that it plays 
important role in microRNA biogenesis. The terminal loops of miR-212 and miR-132 are 
also extremely conserved throughout the vertebrates suggesting that they may bind 
proteins that regulate their processing. This could explain the accumulation of the star 
sequences of both microRNAs and the loop sequence of the pre-miR-132.  
In summary we show here that pri-miR-212/132 is produced from the intron of a 
non-coding immediate early gene, and gives rise to 4 distinct microRNAs.  The 
transcription is strongly regulated by ERK1/2 signalling in neurons, in part through the 
downstream kinase MSK1 and the phosphorylation of CREB.  Previous studies have 
suggested roles for both ERK1/2 and miR-132 in the regulation of neuronal morphology 
[6, 31, 48].  It will therefore be of interest in future studies to examine the in vivo roles of 
both miR-132 and miR-212 in neuronal development. 
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Figure 1 microRNA profiling following BDNF stimulation. 
A) microRNAs were sequenced from unstimulated and BDNF (50 ng/ml, 24 h) 
stimulated cortical neurons.  The sequencing data was analysed as described in the 
methods, and the numbers of sequences that mapped to each pre-microRNA were 
plotted.  MicroRNAs present in only one sample were excluded from the plot. 
B) Comparison of Q-PCR and sequencing results of selected microRNAs (listed in  
table 3).  Error bars for Q-PCR represents the standard error of the mean of 3 
independent stimulations.  Error bars for sequencing data represent estimated 
errors that were calculated as described in the methods. 
C) Primary cortical neuronal cultures were left unstimulated or stimulated with 50 
ng/ml BDNF for the indicated times and miR-132 and miR-212 levels analysed 
by Northern blotting as described in the methods.  Fold induction of the mature 
microRNAs is given above the blots. 
 
Figure 2  BDNF regulates the miR-212/132 genomic locus. 
A) Mir-132 and miR-212 map to the 1st intron of a non-coding mRNA gene on 
chromosome 11 in the mouse genome.   The presence of the three exons predicted 
by from mouse ESTs are indicated (white boxes).  The positions of miR-132 and 
miR-212 in the 1st intron of this gene are shown (vertical lines) and potential 
poly-adenylation sites (AATAAA) are shown (grey vertical lines).  The position 
of the various primer sets used for Q-PCR are marked.  Sequences for these 
primers are given in supplementary table 2. 
B) Primary cortical neuronal cultures were stimulated for the indicated times with 50 
ng/ml BDNF.  Total RNA was isolated, and the fold induction of the processed 
noncoding transcript determined by Q-PCR.  Primers amplifying mRNA derived 
from splicing at the exon 1/2 boundary are shown in the left panel, primers 
detecting splicing at the exon 2/3 boundary in the right panel. 18s RNA levels 
were used to correct for total RNA concentrations.  Error bars represent the 
standard deviation from 3 independent stimulations. 
C) As (B), but Q-PCR was used to determine absolute levels of sequences from 
intron1, exon2, intron 3 and exon 4.  All 4 Q-PCRs were quantified relative to a 
standard curve derived  from a plasmid that contained a subclone of miR-212/132 
genomic region. 18s RNA levels were used to correct for total RNA 
concentrations.  Error bars represent the standard deviation from 3 independent 
stimulations. 
 
Figure 3 ERK1/2 signalling is required for pri-miR-212/132 transcription. 
A) Primary cortical neurons were incubated for 1 h in the presence of 2 µM 
PD184352, 5 µM SB203580, 10 µM Kn93, 10 µM PI103 or 5 µM Bi-D1870 as 
indicated.  Cells were then stimulated for 1 h with 50 ng/ml BDNF and pri-miR-
212/132 levels determined by Q-PCR.  Error bars represent the s.e.m. of three 
independent stimulations. 
B) Primary cortical neurons were incubated for 1 h in the presence of 2 µM 
PD184352 were indicated and then stimulated for 4 or 24 h with 50 ng/ml BDNF.  
Induction of both mature and star microRNA sequences for miR-132 and miR-
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212 determined by Q-PCR.  Error bars represent the s.e.m. of three independent 
stimulations. 
C) The absolute levels of the mature and * microRNA sequences for both miR-132 
and miR-212 were determined by Q-PCR calibrated against a concentration curve 
generated using Q-PCR against a synthetic oligo corresponding to the microRNA 
sequences.  Quantification was carried out for the 4 and 24h BDNF stimulated 
samples described in (B).  
 
Figure 4 MSKs regulate miR-212/132 transcription 
A) Primary cortical neurons were cultured from wild type (black bars) or MSK1/2 
knockout (grey bars) mice.  Cells were stimulated for the indicated times with 50 ng/ml 
BDNF and the fold induction of pri-miR-212/132 determined by Q-PCR.  For both wild 
type and knockout samples, fold change was calculated relative to the wild type control 
samples.  Errors bars represent the s.e.m. of 4 independent stimulations. 
B) As (A) but mature and * microRNA sequences for both miR-132 and miR-212 were 
measured.  
 
Figure 5 miR-212/132 promoter analysis. 
A) Schematic showing the luciferase promoter constructs used. Exon 1 is shown by a 
grey box, miR-132 and miR-212 by diamonds and CRE sites by triangles.  
Mutated CRE sites are indicated by crosses. 
B) The -3105 promoter was transfected into primary cortical neurons. Where 
indicated cells were pretreated for 1 h with 2 µM PD184352. Cells were then 
stimulated for 3 h with 50 ng/ml BDNF.  Luciferase activity was then measured as 
described in the methods.  Error bars represent the standard deviation of 3 
independent stimulations. 
C) The -3105, -475 and Δ intron 1 constructs were transfected into primary cortical 
cultures.  Where indicated cells were stimulated with 50 ng/ml BDNF for 3 h and 
luciferase activity measured. Values are expressed as fold change relative to the 
unstimulated -1306 luciferase vector.  Error bars represent the standard deviation 
of 6 independent stimulations. 
D) The -3105, Cre 2-4, Cre 1 and Cre 1-4 constructs were transfected into primary 
cortical cultures.  Where indicated cells were stimulated with 50 ng/ml BDNF for 
3 h and luciferase activity measured.  Error bars represent the standard deviation 
of 6 independent stimulations. 
 
Figure 6  ERK1/2 regulate miR-212/132 transcription via CREB phosphorylation 
dependent and independent mechanisms. 
A) Primary cortical cultures were established from wild type CREB Nestin-Cre+ve 
(black bars) and CREB Ser133Ala Nestin-Cre+ve (grey bars) mice.  Cultures were 
stimulated with 50 ng/ml BDNF for 1h and the levels of pri-miR-212/132 
determined by Q-PCR.  Error bars represent the s.e.m. of independent cultures 
from 4 (wild type) or 5 (CREB Ser133Ala) mice. 
B) Primary cortical cultures were established from MSK1/2 double knockout mice.  
Cells were preincubated with 2 µM PD 184352 where indicated and then 
stimulated with 50 ng/ml BDNF for 1 h and the levels of pri-miR-212/132 
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determined by Q-PCR.  Error bars represent the s.e.m. of independent cultures 
from 4 mice. 
 
Figure 7 Forskolin and NMDA stimulate pri-miR-212/132 transcription. 
A) Primary cortical neuron cultures were stimulated with 10 µM forskolin for the 
indicated times and pri-miR-212/132 levels determine by Q-PCR  Error bars 
represent the standard deviation of stimulations from 4 independent cultures. 
B) Primary cortical neuron cultures were transfected with either a wild type miR-
212/132 promoter luciferase construct or one in which all 4 potential Cre sites had 
been mutated (see Fig 4A).  Cells were stimulated with 10 µM forskolin for 3 h 
then lysed and luciferase activity measured.  Error bars represent the standard 
deviation of 6 stimulations. 
C) As (A) except that the neurons were stimulated for the indicated times with 20 
µM NMDA. 
D) As (B) except that cells were stimulated with 20 µM NMDA. 
E) Primary cortical neuronal cultures were pretreated with 2 µM PD 184352, 30 µM 
Kn 93 or 10 µM MK 801 as indicated.  Cells were stimulated for 20 min with 20 
µM NMDA lysed and phospho-CREB and total ERK1/2 levels determined by 
immunoblotting. 
F) Primary cortical neuronal cultures were pretreated with 10 mM PD 184352, 30 
uM Kn 93 or 10 µM MK 801 as indicated.  Cells were stimulated for 3 h with 20 
µM NMDA. Pri-mir-212/132 levels were determined by Q-PCR.  Error bars 
represent the s.e.m. of 4 stimulations. 
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Table 1 Small RNA species identified in the sequencing data. 
RNA species were identified by matching sequence reads to miRBase and Ensembl non-
coding RNA data. Matching was performed with Vmatch allowing for up to two 
mismatches per read. 
 
 
 Read Abundance 
RNA species+ Unstimulated control BDNF Stimulated 
microRNA 2,101,986 3,426,272 
Misc. RNA 3,547 8,373 
tRNA 3,069 12,925 
snRNA 2,218 5,996 
rRNA 1,082 3,167 
snoRNA 807 4,184 
Mt rRNA 572 1,494 
Mt tRNA 143 362 




Table 2 microRNAs showing potential induction in the sequencing data. 
pre-miRNA sequences showing the largest fold change in expression when stimulated by 
BDNF. Raw read abundance for each miRNA was normalised by dividing by the total 
number of identified miRNA matches (see Table 1). The change in expression is then 
determined as the ratio of the normalised abundance of BDNF data/Control data. 
Estimated errors, calculated as described in the methods, are shown in brackets. 
 
 
 Read Abundance Normalised Abundance Fold Change in Expression  
miRNA Control BDNF Control BDNF (BDNF/Control) (Error)  
mir-712 1 19 4.76E-07 5.55E-06 11.66 (11.96)  
mir-194-1 1 14 4.76E-07 4.09E-06 8.59 (8.89)  
mir-98 5753 74250 2.74E-03 2.17E-02 7.92 (0.11)  
mir-146a 12 139 5.71E-06 4.06E-05 7.11 (2.14)  
mir-212 30 276 1.43E-05 8.06E-05 5.64 (1.09)  
mir-207 1 9 4.76E-07 2.63E-06 5.52 (5.82)  
mir-381 1 9 4.76E-07 2.63E-06 5.52 (5.82)  
mir-200b 1 8 4.76E-07 2.33E-06 4.91 (5.21)  
mir-483 2 15 9.51E-07 4.38E-06 4.60 (3.46)  
mir-758 1 7 4.76E-07 2.04E-06 4.29 (4.59)  
mir-218-1 3 21 1.43E-06 6.13E-06 4.29 (2.65)  
mir-132 52 353 2.47E-05 1.03E-04 4.16 (0.62)  






Table 3 Comparison and sequencing and Q-PCR data. 
Selected microRNAs from the sequencing results are shown.  Total number of hits 
indicated the number of times a sequence for the pre-microRNA was obtained in the 
RNA sample from the 24h BDNF stimulated neurons.  For each microRNA, the % of hits 
for the potential 5p and 3p microRNA sequences from the hairpin is given, and the 
sequences already annotated in miRBase are also indicated.  In the final columns the fold 
induction between the control and stimulated samples for the sequencing data and Q-PCR 
analysis.  For the sequencing data estimated errors, calculated as described in the 
methods, are shown in brackets.  The Q-PCR was carried out on 3 independent samples, 
and p-values (students t-test) are given for the difference between control and BDNF 
stimulated samples for the PCR results. 
 
 
  Sequencing abundance in BDNF sample fold induction 
 
miRbase 
annotation % 5p  % 3p  total 
Normalised Sequencing 
(Error) Q-PCR P value 
mir-652 3p 0 100 70 1.13 (0.23) 0.87 0.433 
mir-369-3p 5p and 3p 63 37 129 1.30 (0.20) 1.53 0.217 
mir-369-5p      1.90 0.055 
mir-181d 5p 100 0 6302 1.36 (0.03) 1.18 0.719 
mir-146b 5p and * 100 0 571 1.51 (0.12) 1.25 0.118 
mir-669c 5p 100 0 899 1.51 (0.09) 0.78 0.194 
mir-30d 5p 100 0 1087 1.57 (0.09) 0.89 0.552 
mir-30e 5p 100 0 553 1.71 (0.14) 1.34 0.368 
mir-425 5p and * 90 10 33 1.84 (0.64) 0.65 0.264 
mir-433 3p and * 3 97 910 2.03 (0.14) 2.95 0.286 
mir-668 3p 0 100 47 2.40 (0.78) 0.83 0.448 
mir-709 3p 0 100 50 3.41 (1.23) 1.40 0.369 
mir-132 3p 9 84 353 4.16 (0.62) 3.83 0.001 
mir-212 3p 86 14 276 5.64 (1.09) 4.78 0.009 
mir-146a 5p 100 0 139 7.11 (2.14) 1.35 0.034 
mir-98 5p 100 0 74250 7.92 (0.11) 1.78 0.057 
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